Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Human Chimeric Antigen Receptor Modified T Cells (CAR T Cells) in Patients With Pancreatic Cancer

NCT03323944 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT03323944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03323944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Human Chimeric Antigen Receptor Modified T Cells (CAR T Cells) in Patients With Pancreatic Cancer
Lead sponsor
University of Pennsylvania
Phase
Phase 1
Overall status
Terminated
Start date
September 15, 2017
Completion date
February 20, 2025
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the pancreas, pancreatic cancer